ATAI Life Sciences NV
NASDAQ:ATAI
ATAI Life Sciences NV
NASDAQ:ATAI
Price:
3.35
USD
-5.37%
Market Closed
Market Cap:
$1.2B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
ATAI Life Sciences NV
NASDAQ:ATAI
|
DE |
|
NWF Group PLC
LSE:NWF
|
UK |
|
Change Inc
TSE:3962
|
JP |
|
D
|
d'Alba Global Co Ltd
KRX:483650
|
KR |
|
Mayora Indah Tbk PT
IDX:MYOR
|
ID |
|
C
|
Crown Lifters Ltd
NSE:CROWN
|
IN |
|
O
|
Oilex Ltd
LSE:OEX
|
AU |
|
TerraSky Co Ltd
TSE:3915
|
JP |
|
H
|
Hunan Hualian China Industry Co Ltd
SZSE:001216
|
CN |
|
SM Investments Corp
XPHS:SM
|
PH |
Balance Sheet
Balance Sheet Decomposition
ATAI Life Sciences NV
ATAI Life Sciences NV
Balance Sheet Decomposition is not available for
ATAI Life Sciences NV
ATAI Life Sciences NV
Balance Sheet
ATAI Life Sciences NV
ATAI Life Sciences NV
Currency: USD
| Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | Dec-2025 | ||
|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||
| Cash & Cash Equivalents |
30
|
97
|
362
|
191
|
45
|
18
|
85
|
|
| Cash Equivalents |
30
|
97
|
362
|
191
|
45
|
18
|
85
|
|
| Short-Term Investments |
0
|
0
|
0
|
83
|
134
|
45
|
171
|
|
| Total Receivables |
9
|
1
|
6
|
10
|
2
|
1
|
14
|
|
| Accounts Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
1
|
|
| Other Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
14
|
|
| Other Current Assets |
0
|
1
|
7
|
4
|
4
|
16
|
5
|
|
| Total Current Assets |
39
|
100
|
375
|
287
|
186
|
80
|
276
|
|
| PP&E Net |
0
|
0
|
0
|
1
|
2
|
4
|
4
|
|
| PP&E Gross |
0
|
0
|
0
|
0
|
0
|
4
|
4
|
|
| Accumulated Depreciation |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Intangible Assets |
0
|
0
|
0
|
0
|
0
|
3
|
3
|
|
| Goodwill |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Note Receivable |
0
|
2
|
4
|
7
|
11
|
0
|
0
|
|
| Long-Term Investments |
23
|
8
|
28
|
7
|
92
|
71
|
0
|
|
| Other Long-Term Assets |
0
|
2
|
7
|
3
|
3
|
1
|
10
|
|
| Other Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Assets |
62
N/A
|
112
+80%
|
414
+271%
|
305
-26%
|
293
-4%
|
159
-46%
|
293
+84%
|
|
| Liabilities | ||||||||
| Accounts Payable |
1
|
3
|
6
|
2
|
5
|
3
|
5
|
|
| Accrued Liabilities |
1
|
8
|
7
|
15
|
15
|
10
|
14
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Current Portion of Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
9
|
0
|
|
| Other Current Liabilities |
0
|
1
|
8
|
2
|
1
|
3
|
5
|
|
| Total Current Liabilities |
2
|
12
|
21
|
20
|
20
|
25
|
23
|
|
| Long-Term Debt |
0
|
2
|
1
|
15
|
18
|
14
|
0
|
|
| Minority Interest |
1
|
5
|
9
|
5
|
1
|
0
|
0
|
|
| Other Liabilities |
1
|
2
|
7
|
5
|
11
|
4
|
47
|
|
| Total Liabilities |
3
N/A
|
21
+509%
|
37
+80%
|
45
+20%
|
51
+13%
|
43
-15%
|
71
+64%
|
|
| Equity | ||||||||
| Common Stock |
7
|
8
|
18
|
19
|
19
|
19
|
4
|
|
| Retained Earnings |
20
|
189
|
358
|
510
|
551
|
700
|
1 360
|
|
| Additional Paid In Capital |
73
|
266
|
725
|
774
|
795
|
816
|
1 599
|
|
| Other Equity |
1
|
6
|
8
|
22
|
19
|
18
|
21
|
|
| Total Equity |
59
N/A
|
91
+54%
|
377
+315%
|
261
-31%
|
243
-7%
|
116
-52%
|
222
+91%
|
|
| Total Liabilities & Equity |
62
N/A
|
112
+80%
|
414
+271%
|
305
-26%
|
293
-4%
|
159
-46%
|
293
+84%
|
|
| Shares Outstanding | ||||||||
| Common Shares Outstanding |
153
|
153
|
161
|
166
|
166
|
168
|
363
|
|
Switch to:
Switch to:
See Also
Discover More
